CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Cadre Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$27.07+0.69 (+2.62%)

Close on Oct 19, 2026

Market cap: $1.17B
P/E (TTM): 33.4
Dividend yield: 1.40%

Cadre Holdings, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Revenue	610	568	483	458	427	405
Cost of Revenue	351	334	282	282	257	252
Gross Profit	260	233	201	176	171	153
Research & Development	11	8.38	6.95	7.09	6.46	5.63
Selling, General & Admin	183	158	141	153	115	107
Advertising Expenses	6.76	5.94	6.15	4.71	3.12	–
Operating Expenses	192	167	144	159	119	103
Operating Income	67	67	57	17	52	50
Interest Expense	–	7.82	4.53	6.21	16	24
Other Non-Operating Income	-5.03	-13	-3.60	-7.34	-33	-22
Merger & Restructuring Charges	7.70	6.01	2.19	4.36	3.43	5.82
Asset Impairment Charges	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	–	–	–	0.17	–	6.24
Pretax Income	62	54	53	9.37	19	28
Income Tax Expense	18	18	14	3.55	6.53	-11
Net Income incl. Noncontrolling Interests	44	36	39	5.82	13	-38
Net Income	44	36	39	5.82	13	38
Net Income to Common	44	36	39	5.82	13	38
EPS (Basic)(per share)	1.08	0.90	1.03	0.16	0.44	1.40
EPS (Diluted)(per share)	1.02	0.90	1.02	0.16	0.44	1.40
Shares Outstanding (Basic, Weighted)(shares)	41	40	38	36	29	27
Shares Outstanding (Diluted, Weighted)(shares)	43	40	38	36	29	27
Dividend per Share(per share)	0.38	0.35	0.08	0.08	–	–
EBITDA	86	83	72	32	65	65

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 41.8%
Operating margin: 10.1%
Net margin: 5.3%
Return on equity, FY2025: 14.0%

Financial strength

Current ratio: 2.14
Debt to equity: 1.08
Debt to assets: 40.8%
Cash to current liabilities: 33.2%

Valuation

P/E ratio: 33.4
Price to sales: 1.71
Price to book: 3.39
Dividend yield: 1.40%